Introduction and Objective: Metformin, the first-line treatment for type 2 diabetes, exerts antidiabetic effects partly through gut microbiota modulation. However, it can also increase Escherichia species capable of inducing endotoxemia via lipopolysaccharide (LPS). This study investigated metabolic endotoxemia, represented by LPS-binding protein (LBP) and its antagonist bactericidal/permeability-increasing protein (BPI), in relation to therapeutic responses to […]
Read MoreMonth: July 2025
523-P: Seeking Methods to Engage Emerging Adults (EAs) with Type 1 Diabetes (T1D) in Diabetes Self-Management Education and Support (DSMES)—A Human-Centered Design Approach
Introduction and Objective: DSMES is considered a cornerstone of diabetes care. EAs with T1D are reported to have alarmingly low DSMES participation rates yet doing most of their self-care. In its present form, DSMES has been cited for not meeting EAs’ needs. Our objective was to discover factors affecting DSMES engagement and use a collaborative […]
Read More1678-P: Weight-Independent GLP-1RA Effects on Adipose Tissue PGC1-α and TERT in Insulin-Resistant Humans
Introduction and Objective: Induced adipocyte browning, in limited subcutaneous adipose tissue (SAT) human depots via cold activation or weight loss, confers anti-diabetic/obesity function via thermogenesis. Peroxisome proliferator-activated receptor-γ coactivator (PGC1-α) regulates mitochondrial biogenesis in adipose tissue (AT), and may activate telomerase reverse transcriptase (TERT), which regulates cellular aging. AT browning exists in GLP-1RA-treated patients with […]
Read More522-P: Utilization of Personal Continuous Glucose Monitoring (CGM) Systems in the Inpatient Setting
Introduction and Objective: This pilot study sought to compare glucose outcomes and provider insulin dosing confidence in individuals using personal CGM while in the hospital compared to those receiving point of care blood glucose (POC BG) monitoring only.Methods: Hospitalized individuals followed by the diabetes service and expected to be discharged on insulin were included. Diabetes […]
Read More652-P: Effectiveness of a Digital Lifestyle Intervention for Glycemic Control in People with Type 2 Diabetes
Introduction and Objective: This study aims to evaluate the effectiveness of a digital lifestyle-based interventional program, developed by us, [D-LITE (Diabetes- Lifestyle Intervention for Therapeutic Enhancement)], on metabolic control in individuals with diabetes.Methods: An online diabetes management program utilizing a WhatsApp-based model facilitated continuous and collaborative care among patient, a dietitian, and physicians. The program […]
Read More521-P: Greater Participation in Diabetes Management Coaching Program Improves Glycemic Control and Diabetes Distress
Introduction and Objective: Virtual diabetes management platforms can be used to improve glycemic control for people with diabetes. The objective of this study was to evaluate the effectiveness of the Diabetes Care Management coaching program in the Wellworks for You© (WW) chronic disease management virtual platform.Methods: A cohort of people with diabetes enrolled in the […]
Read More64-PUB: Comparison of Body Mass Index and Bioelectric Impedance Analysis for Clinical Assessment of Obesity
Introduction and Objective: Body mass index (BMI), weight adjusted for height, is an imprecise tool for the diagnosis of obesity. Body composition assessment with bioelectric impedance analysis (BIA) scales estimate fat mass and % adiposity, offering a more precise diagnosis of obesity. The objective of this project was to compare the use of BMI and […]
Read More520-P: School Day Disruptions in Type 1 Diabetes (T1D) Management—Early Experiences from the School-Partnered Collaborative Care (SPACE) Study Highlight an Unmet T1D Education Need
Introduction and Objective: T1D management may require frequent interventions which disrupt the school day, though the missed class time and impact on students are not described. We aimed to determine the frequency, duration, and type of school disruptions for students with T1D.Methods: We analyzed data for 16 children (age 9.0±1.8 years, 62% female, 31% public […]
Read More1057-P: Cost Analysis of Freestyle Libre Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c >8%)—A Societal Perspective in Spain
Introduction and Objective: This cost analysis compared FreeStyle Libre® systems (FSL) vs self-monitoring of blood glucose (SMBG) in T2D patients on basal insulin and poorly controlled (HbA1c > 8%), from a societal perspective in Spain.Methods: A model compared costs (€2024) of FSL and SMBG in a cohort of 1,000 T2D patients. The inputs, validated by […]
Read More51-PUB: Prescription of Thyroid Hormone Replacement Therapy in Individuals with Diabetes in Spain—Differences by Sex, Age, and Temporal Trends (2018–2023)
Introduction and Objective: Diabetes mellitus (DM) is a chronic condition characterized by elevated blood glucose levels due to insufficient insulin production or ineffective utilization. DM often coexists with thyroid diseases, particularly hypothyroidism, which can impact glycemic control and increase the risk of complications. Thyroid replacement therapy, typically with levothyroxine, is crucial for managing hypothyroidism in […]
Read More